- RxSight ( NASDAQ: RXST ) priced a common stock offering to raise ~$50M in gross proceeds.
- The company expects to sell 4M shares at $12.50 apiece.
- RxSight granted the underwriter a 30-day option to buy up to an additional 600K shares
- The medical device maker plans to use the net proceeds for marketing expansion, funding product, research and clinical development, and for working capital and general corporate purposes.
- The offering is expected to close on Feb. 10.
- RXST -9.22% to $12.50 premarket Feb. 8
For further details see:
RxSight slumps on pricing $50M common stock offering